ARTICLE | Distillery Therapeutics
Hepatic
February 28, 2017 11:55 PM UTC
Mouse studies suggest inhibiting NCOR1 could help treat neonatal hyperbilirubinemia. In a humanized mouse model of the disease, intestine-specific knockout of NCOR1 decreased total levels of bilirubin...
BCIQ Company Profiles
BCIQ Target Profiles